Abivax S.A. (ABVX)
Abivax S.A. (ABVX) is a Healthcare stock tracked by StreetAlpha. It last closed at $95.10 on Oct 1. ABVX reports earnings on Mon, Dec 21, 2026. The average 12-month price target from 4 analysts is $149.75 (+57.5% from the last close), with a high of $175.00 and a low of $118.00. Analyst consensus is Strong Buy, based on the latest ratings from 4 firms (3 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 6 whale options trades in ABVX, 33% of them bullish and 67% bearish. In the past 30 days there were 6 dark pool prints totaling $8.5M, the largest $2.9M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 4 analysts who set a price target on ABVX in the past 90 days. The average target is $149.75, with a high of $175.00 and a low of $118.00, compared with the last close of $95.10.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Sep 22 | Truist Securities | Target lowered | Buy | $155 → $151 |
| Sep 22 | Wedbush | Target raised | Hold | $90 → $118 |
| Sep 10 | Goldman Sachs | Initiated | Buy | $155 |
| Jul 9 | Piper Sandler | Maintained | Buy | $175 |
| Jul 2 | Truist Securities | Target raised | Buy | $135 → $155 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABVX is in one of them and how their past ABVX trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered ABVX in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.